| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -11.7% |
| Cost of Revenue | $2.1M | -23.3% |
| Gross Profit | $1.4M | +14.0% |
| R&D Expense | $662K | +0.0% |
| SG&A Expense | $2.3M | +10.1% |
| Operating Income | $585K | +226.1% |
| Interest Expense | $39K | — |
| Pre-tax Income | $919K | +300.2% |
| Net Income | $935K | +228.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -85.9% |
| Short-term Investments | $14.8M | +0.0% |
| Accounts Receivable | $671K | -6.7% |
| Inventory | $325K | -50.6% |
| Current Assets | $2.9M | -89.8% |
| Total Assets | $6.0M | -80.8% |
| Current Liabilities | $1.2M | -25.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | $16.7M | +2512.8% |
| Financing Cash Flow | -$25.8M | — |
| Long-term Debt |
| $1.6M |
| — |
| Total Liabilities | $2.8M | +72.4% |
| Stockholders' Equity | $3.2M | -89.1% |